eBay Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? eBay Inc trades at $111.7 (market cap $47.88B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: eBay Inc is the larger of the two by market cap, and eBay Inc pays a 1.15% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold eBay Inc for 134 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| EBAY | ROIV | |
|---|---|---|
Market Cap | $47.88B | $25.09B |
Volume | 2,781,198 | 5,738,571 |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $41.81 |
52-Week Low | $79.41 | $16.04 |
Typical Hold Time | 134 Days | 0 Days |
Enterprise Value | $51.71B | $21.36B |
Dividend Yield | 1.15% | — |
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $111.98, up 4.6% with bullish technical signals and strong earnings momentum after beating Q2 2026 estimates. The company maintains robust profitability with 72% gross margins and 47% ROE, while analyst consensus targets $117.68. Recent news highlights strategic focus on collectibles and live commerce growth, though GameStop's acquisition interest and executive selling warrant monitoring.
EBAY presents a balanced investment case with solid fundamentals and positive technicals, but faces competitive pressures from Amazon's multi-platform tools and potential acquisition uncertainty. The stock offers moderate upside to consensus targets with execution-dependent growth in key verticals.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →